Post by Admin on Sept 6, 2014 1:46:18 GMT
I just came across new information from Psyadon Pharmaceutical's regarding a clinical trial of Ecopipam for the treatment of Tourette's Syndrome. This trial is for children ages 7-17.
Quoting Psyadon Parmaceutical's info "This study involves the medication Ecopipam, which has a safety profile based on use in over 2,000 adults. The current Phase 2b study is based on previous positive results showing that Ecopipam significantly reduced the symptoms of Tourette's Syndrome in adults."
For more information please see: sites.google.com/site/tourettesclinicaltrial/
Quoting Psyadon Parmaceutical's info "This study involves the medication Ecopipam, which has a safety profile based on use in over 2,000 adults. The current Phase 2b study is based on previous positive results showing that Ecopipam significantly reduced the symptoms of Tourette's Syndrome in adults."
For more information please see: sites.google.com/site/tourettesclinicaltrial/